| P2093 | author name string | Peter J Allen | |
| | Mohammad Al Efishat | |
| P2860 | cites work | Patterns of Recurrence After Resection of IPMN: Who, When, and How? | Q38385287 |
| | Endoscopic Ultrasonography-Guided Ethanol Lavage With Paclitaxel Injection Treats Patients With Pancreatic Cysts | Q38480644 |
| | Septated cystic tumors of the pancreas: is it possible to treat them by endoscopic ultrasonography-guided intervention? | Q38498252 |
| | Success of endoscopic ultrasound-guided ethanol ablation of pancreatic cysts: a meta-analysis and systematic review | Q38537213 |
| | Left-sided pancreatectomy: a multicenter comparison of laparoscopic and open approaches | Q42597341 |
| | Cyst growth rate predicts malignancy in patients with branch duct intraductal papillary mucinous neoplasms. | Q44537497 |
| | EUS-guided ethanol versus saline solution lavage for pancreatic cysts: a randomized, double-blind study. | Q45939797 |
| | Ethanol lavage of pancreatic cystic lesions: initial pilot study | Q46459210 |
| | New treatment for cystic tumors of the pancreas: EUS-guided ethanol lavage with paclitaxel injection | Q46762767 |
| | Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an "intestinal" pathway of carcinogenesis in the pancreas | Q47272497 |
| | Pancreatic enucleation: improved outcomes compared to resection | Q47862149 |
| | Prevalence of incidental pancreatic cysts in the adult population on MR imaging | Q57645260 |
| | The outcome of resected cystic pancreatic endocrine neoplasms: A case-matched analysis | Q57823401 |
| | A selective approach to the resection of cystic lesions of the pancreas: results from 539 consecutive patients | Q57823607 |
| | Intraductal papillary mucinous neoplasms of the pancreas: an increasingly recognized clinicopathologic entity | Q74428893 |
| | Pancreatic mucinous cystic neoplasm defined by ovarian stroma: demographics, clinical features, and prevalence of cancer | Q81025016 |
| | Controversies in the management of pancreatic IPMN | Q83146429 |
| | Natural history of intraductal papillary mucinous tumors of the pancreas: actuarial risk of malignancy | Q83157628 |
| | Cyst fluid carcinoembryonic antigen is an accurate diagnostic marker of pancreatic mucinous cysts | Q84580136 |
| | Growth pattern of serous cystic neoplasms of the pancreas: observational study with long-term magnetic resonance surveillance and recommendations for treatment | Q84975359 |
| | Clinicopathological features and prognosis of mucinous cystic neoplasm with ovarian-type stroma: a multi-institutional study of the Japan pancreas society | Q85160836 |
| | Prevalence of unsuspected pancreatic cysts on MDCT | Q24650018 |
| | Pancreatic cystic neoplasms: Review of current knowledge, diagnostic challenges, and management options | Q26865466 |
| | Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology | Q34583263 |
| | Resected serous cystic neoplasms of the pancreas: a review of 158 patients with recommendations for treatment | Q34620062 |
| | Cyst fluid interleukin-1beta (IL1beta) levels predict the risk of carcinoma in intraductal papillary mucinous neoplasms of the pancreas. | Q34729696 |
| | Surgical management of solid-pseudopapillary neoplasms of the pancreas (Franz or Hamoudi tumors): a large single-institutional series | Q35030363 |
| | Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics | Q35102198 |
| | GNAS and KRAS Mutations Define Separate Progression Pathways in Intraductal Papillary Mucinous Neoplasm-Associated Carcinoma | Q35537214 |
| | Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study | Q36222863 |
| | Fate of the remnant pancreas after resection of noninvasive intraductal papillary mucinous neoplasm. | Q36811667 |
| | A systematic review of solid-pseudopapillary neoplasms: are these rare lesions? | Q36954169 |
| | Recurrence and Survival After Resection of Small Intraductal Papillary Mucinous Neoplasm-associated Carcinomas (≤20-mm Invasive Component): A Multi-institutional Analysis | Q37117829 |
| | Diagnosis and management of cystic neoplasms of the pancreas: an evidence-based approach | Q37203140 |
| | Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients | Q37249734 |
| | Cystic lesions of the pancreas: changes in the presentation and management of 1,424 patients at a single institution over a 15-year time period | Q37279916 |
| | Patient outcomes after total pancreatectomy: a single centre contemporary experience | Q37374094 |
| | Increased Prevalence of Precursor Lesions in Familial Pancreatic Cancer Patients | Q37480736 |
| | Is it necessary to follow patients after resection of a benign pancreatic intraductal papillary mucinous neoplasm? | Q37657085 |
| | Pancreatic cystic neoplasms: diagnosis and management | Q37984980 |
| | International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas | Q38017783 |
| | Systematic review of central pancreatectomy and meta-analysis of central versus distal pancreatectomy. | Q38103822 |
| | What to do for the incidental pancreatic cystic lesion? | Q38213360 |
| | IPMN involving the main pancreatic duct: biology, epidemiology, and long-term outcomes following resection | Q38224748 |
| P433 | issue | 2 | |
| P921 | main subject | pancreas | Q9618 |
| P304 | page(s) | 351-361 | |
| P577 | publication date | 2016-04-01 | |
| P1433 | published in | Surgical oncology clinics of North America | Q25379760 |
| P1476 | title | Therapeutic Approach to Cystic Neoplasms of the Pancreas | |
| P478 | volume | 25 | |